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Abstract: Sufficient supply of oxygen is a major bottleneck in industrial biotechnological synthesis. One
example is the heterologous production of rhamnolipids using Pseudomonas putida KT2440. Typically,
the synthesis is accompanied by strong foam formation in the reactor vessel hampering the process.
It is caused by the extensive bubbling needed to sustain the high respirative oxygen demand in the
presence of the produced surfactants. One way to reduce the oxygen requirement is to enable the cells
to use the anode of a bioelectrochemical system (BES) as an alternative sink for their metabolically
derived electrons. We here used a P. putida KT2440 strain that interacts with the anode using
mediated extracellular electron transfer via intrinsically produced phenazines, to perform heterologous
rhamnolipid production under oxygen limitation. The strain P. putida RL-PCA successfully produced
30.4± 4.7 mg/L mono-rhamnolipids together with 11.2± 0.8 mg/L of phenazine-1-carboxylic acid (PCA)
in 500-mL benchtop BES reactors and 30.5 ± 0.5 mg/L rhamnolipids accompanied by 25.7 ± 8.0 mg/L
PCA in electrode containing standard 1-L bioreactors. Hence, this study marks a first proof of concept
to produce glycolipid surfactants in oxygen-limited BES with an industrially relevant strain.
Keywords: Pseudomonas putida; rhamnolipid; bioelectrochemical system; phenazines; redox mediator;
microbial electrosynthesis; electrobiotechnology; metabolic engineering
1. Introduction
Rhamnolipids (RL) are among the best explored microbial glycolipid surfactants. The combination
of one or two hydrophilic rhamnose monosaccharides with lipid chains of different length and different
degree of saturation (called congeners) [1,2], provides a large range of specific properties [3]. Rhamnolipids
possess eco-friendly characteristics such as biodegradability, a low eco-toxicity, and they can be produced
from renewable resources [4]. The expansion of their production to industrial scale is therefore desirable.
However, the biotechnological production with the native microbial producers, especially with Pseudomonas
aeruginosa, is not desirable. P. aeruginosa is a facultative pathogen and its rhamnolipid production is
controlled by a complex quorum sensing network [5–7]. Hence, research in the past years has focused on
heterologous production with the non-pathogenic P. putida KT2440 [8–10].
Metabolic engineering of P. putida KT2440 for rhamnolipid production was previously developed
and tested under aerobic conditions [3,10,11] (Figure 1). However, the costly aeration and the subsequent
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problems with strong reactor foaming still impose severe technical challenges [12]. This also hinders the
scale-up of the process towards the industrial production of rhamnolipids and it requires substantial
technical effort to overcome this challenge [13–16]. To reduce this bottleneck, which comes with the need
for sufficient oxygen supply for aerobic growth and product synthesis, we here explore an alternative
approach for rhamnolipid production using P. putida as a biocatalyst under oxygen-limitation in
bioelectrochemical systems (BESs). BESs couple the metabolic activity and product formation of
microorganisms to an electron transfer with an extracellular electrode, for instance, the discharge of
surplus metabolic electrons to an anode [17].
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Figure 1. Sche atic representation of the (a) rha nolipid production and (b) phenazine biosynthesis
pathways in P. putida KT 2440. The proteins needed for the heterologous production are highlighted in
orange and were expressed via two plasmids.
The implementation of the BES technology for rhamnolipid producti n is based on th successful
heterologous producti n of phenazines serving as redox mediators in P. putida for mediated extracellular
electron transfer (MET; Figure 1) [18,19]. Using MET, the obligate aerobic organism P. putida KT2440
was enabled to stay metabolically active under oxygen-limited conditions in a BES through the
electron discharge to an extracellular anode. Metabolic activity was evaluated under different
aeration scenarios, and it was shown that the best regime for phenazine- and current production was
an initial active aeration of the media for 48 h, followed by passive aeration of the headspace through
open vent filters until the end of cultivation. With this set-up, depending on the strain, the redox
mediators phenazine-1-carboxylic acid (PCA) and/or pyocyanin (PYO) were continuously produced,
and anodic current could be sustained for more than 10 days [18]. While this route of anodic MET
in P. putida still is limited and work is ongoing to enhance the efficiency of electron discharge [19],
the technical exploitation of the sustained metabolic activity can already be evaluated with a relevant
biotechnological synthesis.
We here evaluated if both, phenazine mediator production and rhamnolipid production, can be
heterologously engineered into a single strain of P. putida KT2440. The strain was first evaluated in classical
fully aerobic cultivations and then further assessed for bioelectrochemical production with active aeration
for 48 h followed by passive aeration (AA), a continuous active aeration (AA+), and passive aeration from
the start (PA) in BES benchtop reactors. The most successful operational scheme was finally up-scaled and
reconfirmed in 1-L electrobioreactors, which are continuous stirred tank bioreactors fully standardized
for electrochemical operation [20]. The successful prove of concept portrait in this work, opens the door
for a wider use of microbial electrosynthesis by decreasing the need for oxygen in otherwise obligate
aerobic processes.
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2. Materials and Methods
2.1. Bacterial Strains, Strain Cultivation and Media Preparation
The Pseudomonas putida strain KT2440 (DSM 6125) served as the recipient for the rhamnolipid
biosynthesis genes rhlAB of P. aeruginosa PAO1 (DSMZ 19880) and the phenazine biosynthesis genes
phzA2-G2 of P. aeruginosa PA14 (DSMZ 19882, [19]). 250 mL shake flasks were used for standard
strain cultivations with LB medium (Carl Roth, Karlsruhe, Germany) with or without the addition
of antibiotics (as required). P. putida cultures were incubated at 30 ◦C and P. aeruginosa cultures at
37 ◦C. For all reported experiments (shake flasks, BES experiments and well plates), P. putida was
grown at 30 ◦C in Delft mineral salt medium [21], in short, the final composition (per L) consisted of
3.88 g K2HPO4 (22 mM), 1.63 g NaH2PO4 (14 mM), 2 g (NH4)2SO4, 0.1 g MgCl2·6H2O, 10 mg EDTA,
2 mg ZnSO4·7H2O, 1 mg CaCl2·2H2O, 5 mg FeSO4·7H2O, 0.2 mg Na2MoO4·2H2O, 0.2 mg CuSO4·5H2O,
0.4 mg CoCl2·6H2O, 1 mg MnCl2·2H2O, with 5 g/L (27 mM) (passive aeration), 10 g/L (55 mM) (active
aeration), or 5 g/L (27 mM) (electrobioreactors) glucose. Glucose concentration was lower at PA
configuration, as the metabolic activity of P. putida is known to be greatly reduced at this condition [19].
Antibiotics were added as required (50 µg/mL kanamycin or/and 30 µg/mL gentamycin). In the
electrobioreactors, 37.5 instead of 30 µg/mL gentamycin were used to increase plasmid stability.
2.2. Combining Heterologous Rhamnolipid and Phenazine Production in P. putida
All plasmids and strains used in this study are shown in Table 1. Phenazine production plasmids
have been generated previously [19]. The genes rhlA and rhlB for rhamnolipid production originated
from P. aeruginosa PAO1 and were previously cloned into the pSK02 plasmid [16], which served as the
template for this study. Plasmids were assembled via Gibson assembly (New England Biolabs-Gibson
Assembly) [22]. The rhlAB genes were inserted into the pJNN backbone and the pJNN.phzMS
plasmid to generate pJNN.rhlAB and pJNN.rhlAB.phzMS, respectively (Supplementary Materials
Figure S1). Subsequently, these plasmids were transformed into P. putida KT2440 via electroporation [23].
Transformed cells were selected on LB agar plates with gentamycin.
Table 1. Bacterial strains and plasmids used for tailoring heterologous rhamnolipid production with
phenazine producing P. putida.
Strains/Plasmids Characteristics Source
Strains
P. aeruginosa PAO1 Wildtype DSMZ
P. putida 14phz2 PCA producer [19]
P. putida RL RL producer this study
P. putida RL-PCA PCA and RL producer this study
P. putida RL-MS PhzMS and RL producer this study
P. putida RL-PYO PCA, PYO, and RL producer this study
Plasmids
pJNN.rhlAB
oriRO1600 for Pseudomonas and oriCoIE1 for E. coli; gentamycin
resistance-cassette, salicylate-inducible nagR/pNagAa
promoter, rhlA and rhlB genes (P. aeruginosa PAO1)
this study
pJNN.rhlAB.phzMS
oriRO1600 for Pseudomonas and oriCoIE1 for E. coli; gentamycin
resistance-cassette, salicylate-inducible nagR/pNagAa
promoter, phzM, phzS, rhlA and rhlB genes (P. aeruginosa PAO1)
this study
pBNT.14phz2
ORI: ori/IHF for replication in E. coli and Pseudomonas;
kanamycin resistance-cassette, salicylate-inducible
nagR/pNagAa promoter, phzA2-G2 genes (P. aeruginosa PA14)
[19]
pSK02
oriR6K-pir dependent origin of replication; oriI -origin of
transfer; riboJ gene; kanamycin resistance-cassette, rhlA and
rhlB genes (P. aeruginosa PAO1)
[16]
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To verify the constructs, colony PCR, as well as restriction digest analysis, and DNA sequencing
(GATC-Eurofins Genomics) was used. The respective primers for DNA sequencing are shown in
Table S1. Subsequently, the pBNT14.phz2 plasmid was transformed into the P. putida RL and P. putida
RL-MS strains via electroporation [23]. The selection procedure was identical to the rhlAB containing
plasmids but using a combination of kanamycin and gentamycin for selection (50 µg/mL kanamycin
and 30 µg/mL gentamycin).
2.3. Aerobic Strain Characterization and Evaluation
In order to evaluate the production of phenazines and/or rhamnolipids, a total of eight clones per
constructed strain were analyzed in triplicates using a multiplexed micro-cultivation platform (CR1424d,
EnzyScreen, Heemstede, The Netherlands), in 24 square-well plates filled with 5 mL Delft medium,
with 20 mM added glucose, and supplemented with the respective antibiotics. Afterwards, 250 mL
Erlenmeyer flasks; filled with 25 mL Delft medium were used for aerobic shake flask experiments. For
both types of cultivations, the starting OD600 was 0.1. After three hours of incubation, 0.1 mM (for
phenazine production) and 1 mM (for combined phenazine- and rhamnolipid production) sodium
salicylate was added as an inducer for gene expression. The incubation temperature was always at 30 ◦C,
while the shaking frequency depended on the type of cultivation and was 224 rpm for the multiplexed
cultivation and 200 rpm for the shake flasks. The best performing clone of each constructed strain from
the multiplex cultivation was selected and further characterized in aerobic shake flasks—as well as
BES experiments.
2.4. Bioelectrochemical Experiments
The benchtop single chamber glass BES reactors (500 mL working volume) included a water
jacket for temperature control [19]. A three-electrode set-up was used, including (i) a graphite comb of
high grade graphite (EDM-3, Novotec) as the working electrode (anode, surface area: 156.32 cm2);
(ii) a graphite block (made of the same material as the working electrode) as the counter electrode
(cathode, surface area: 49.22 cm2); and (iii) a self-assembled Ag/AgCl, saturated KCl reference electrode
(RE; 197 mV vs. SHE at 25 ◦C, all potentials are given vs. this reference). BES experiments were
generally run with the anode poised at 0.2 V vs. RE. The RE was made by electrochemically oxidizing
a silver wire at a potential >0.5 V for 10 min in a concentrated KCl solution. The wire was thereafter
embedded into a saturated KCl agar matrix (~3–4 M KCl; ~1.5% [w/v] of agar), acting as the electrolyte,
within a thin glass shaft. The bottom end of the shaft was a MgO frit to ensure ionic exchange between
the reference electrode and the reactor medium. Potentials were verified against a commercial Ag/AgCl
reference electrode before and after BES experiments. The reactors were controlled by a potentiostat
(VMP3, BioLogic) at 0.2 V. To provide the best conditions for the bioelectrochemical production of
rhamnolipids, several different strategies for oxygen limitation of the benchtop BES reactors were
tested in triplicates: (i) active aeration via a sparger at a flow rate of 30 mL/min for 48 h, followed by
passive aeration of the head space via two open vent filters (AA); (ii) continuous active aeration at
a flow rate of 30 mL/min (or 50 mL/min where indicated) (AA+); or (iii) passive aeration via open vent
filters for the entire experiment (PA). Oxygen levels were measured discontinuously for evaluation
purpose in the benchtop BES reactors via a VisiFerm DO Arc sensor (Hamilton). For this set-up passive
aeration corresponds to a range of 50–80 dissolved oxygen/ppb, while in active aerated reactors the
dissolved oxygen/ppb was at 1500–2500.
For synthesis at a 1 L-scale, electrobioreactor were employed. They are based on commercial bioreactor
vessels (Infors Multifors, Infors AG, Bottmingen, Switzerland) equipped with an electrochemical upgrade
kit [20,24,25]. In brief, the kit consists of a custom-made polyetheretherketon (PEEK) reactor lid including
all connectors and containing an inner compartment with three side openings (total window area 21.48 cm2)
to allow mixing throughout the reactor. The reactor was filled with 750 mL working volume. The two
25 cm long graphite rods (10 mm diameter, CP-2200 quality, CP-Handels GmbH, Wachtberg, Germany)
acting as working electrodes were placed in the outer anode compartment (total surface area 76.97 cm2),
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while two identical rods were located within the inner cathode compartment. A commercial Ag/AgCl
reference electrode was used (sat. KCl, SE11, with 6 mm diameter, and 100 mm length, Xylem Analytics,
Meinsberg, Germany). Additionally, the pH, temperature and pO2 were continuously measured using
the integrated sensors of the Infors Multifors system. Here, pO2 is measured via a Clark electrode. If the
pH dropped below a value of 6.5, it was titrated with 10% NaOH solution. These reactors were also
potentiostatically controlled (VMP3, BioLogic) at an anodically applied potential of 0.2 V vs. RE and
operated with the AA or the PA set-up. As the pO2 sensors in the electrobioreactors measure the off gas,
they need a constant airflow and could therefore record no values at PA set-up. For the initially active
aerated electrobioreactors pO2 was down to 0.06% for the metabolically active phase.
Cultivation temperature for all BES experiments was 30 ◦C at a stirring speed of 200 rpm via
a magnetic stirrer. The amount of produced current (chronoamperometry) was recorded continuously
(once every minute), after 24 h of blank media measurement. Sampling for pH, HPLC analysis,
and optical density measurements at 600 nm was performed daily. Except when indicated otherwise,
all experiments were run as independent biological triplicates. Where applicable, the data is given
with standard deviation.
2.5. Analysis of Sugar Metabolites
The amount of glucose and secreted metabolites was measured via an HPLC containing a 300× 8.0 mm
polystyroldivinylbenzol copolymer separation column (CS-Chromatographie, Langerwehe, Germany).
For the detection, a UV/VIS detector at 210 nm and a refractive index (RI) detector at 35 ◦C were employed.
The mobile phase consisted of 5 mM sulphuric acid applied at an isocratic flow rate of 0.8 mL/min,
at a separation temperature of 60 ◦C. As standard solutions, analytical grade glucose, gluconate,
2-ketogluconate, and acetate (all Carl Roth) were used. Due to a change in the lab facility, the metabolites
of the electrobioreactor experiments were measured on a Aminex HPX-87H ion exclusion column
(300 mm × 7.8 mm, 9 µm; Bio-Rad, Hercules, CA, USA) and a Kromasil 100 C (18, 40 mm × 4 mm, 5 µm;
Dr. Maisch GmbH, Ammerbuch-Entringen, Germany) precolumn. The separation occurred at a flow rate
of 0.5 mL/min at 50 ◦C. Detection method and running buffer were identical.
2.6. Phenazine Analysis
Phenazines were quantified via an HPLC equipped with a C18 column (Waters Corporation)
coupled with a photodiode array UV/VIS detector (LC-168, BecKann, Brea, CA, USA). Detection and
quantification of PCA was achieved at 366 nm and of PYO at 280 nm. External standard solutions were
prepared with analytical grade PCA (Princeton Biomolecular, Princeton, NJ, USA) and PYO (Cayman
Chemical). For separation, a gradient of 0.1% trifluoroacetic acid (TFA) in acetonitrile (solution A)
and 0.1% TFA in water (solution B) was used as the mobile phase (regime: 15% solution A for 2 min,
followed by 100% for 15 min, and finished at 5% for 3 min) at a column temperature of 20 ◦C and a flow
rate of 0.8 mL/min [26]. Due to a change in the lab facility, PCA in the electrobioreactor experiments was
measured on a Prontosil 120-5-C18 ACE-EPS 250 × 4.0 mm (BISCHOFF Analysentechnik, Leonberg,
Germany) column on a JASCO HPLC system equipped with a multi wavelength detector (MD-1515,
JASCO International Co, Tokyo, Japan). The regime of solution A and B was changed to 10% solution
A for 2 min, 50% for 10 min, 70% for 8 min, and 100% for 7 min at a flow rate of 1 mL/min.
2.7. Rhamnolipid Analysis
The quantification of rhamnolipids was performed using a reversed-phase HPLC equipped
with a NUCLEODUR C18 Gravity column (Macherey-Nagel GmbH & Co. KG, Düren, Germany)
(dimensions: 150 × 4.6 mm; particle size: 3 µm). The Ultimate 3000 HPLC system was equipped with
a Corona-charged aerosol detector (CAD) (Thermo Fisher Scientific Inc., Waltham, MA, USA). The flow
rate was 1 mL/min at 40 ◦C. Separation was achieved with a gradient of 100% acetonitrile (eluent
A) and ultra-pure water containing 0.2% (v/v) formic acid (eluent B) as a buffer (70% eluent A for
9 min, 100% for 3 min, and 70% for 3 min) [10]. Due to a change in the lab facility, rhamnolipids of the
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electrobioreactor experiments were measured on a HPLCJAS2 system (JASCO International Co, Tokyo,
Japan) with a NUCLEODUR C18 Gravity column (250 × 2 mm, 3 µm; Macherey-Nagel GmbH & Co.
KG, Düren, Germany). Detection was achieved via an evaporative light scattering detector (ELSD)
(Evaporator 80 ◦C, Nebulizer 30 ◦C, Gas flow 1 SLM) at 35 ◦C. The regime was changed to 50% eluent
A for 25 min, a ramp to 100% for 2 min, running at 100% for 5 min and a 2 min ramp down to 50%.
3. Results
3.1. Tailoring Heterologous Mono-Rhamnolipid Synthesis with Phenazine Production in P. putida
Our work started with a PCA producing strain of P. putida KT2440 carrying the plasmid pBNT.14phz2
for the expression of the genes phzA2-G2 from P. aeruginosa PA14, as this strain showed superior phenazine
production and bioelectrochemical activity in our previous work [19]. The genes rhlAB, responsible for
mono-rhamnolipid expression in P. aeruginosa PAO1, were cloned into the salicylate inducible plasmid
pJNN. Additionally, the previously used plasmid pJNN.phzMS, carrying genes required to turn PCA into
PYO [18], was modified to contain rhlAB resulting in the pJNN.rhlAB.phzMS plasmid. These plasmids
were separately transformed into the PCA producing P. putida KT2440 strain. The first resulting strain,
P. putida RL-PCA, carrying pBNT.14phz2 and pJNN.rhlAB, should be able to produce mono-rhamnolipids
and PCA. The second strain, P. putida RL-PYO, containing pBNT.14phz2 and pJNN.rhlAB.phzMS, should
represent a mono-rhamnolipid, PCA, and PYO producer. As a control, both pJNN plasmids were also
transformed into the P. putida KT4220 wildtype to evaluate rhamnolipid production without phenazines
(see Table 1 for details).
The growth behavior and product formation of eight picked colonies was compared on
a multiplexed micro-cultivation platform [27] under aerated conditions. While P. putida RL-PCA
produced a maximum of 110.0 ± 0.5 mg/L mono-rhamnolipids and 54.4 ± 8.4 mg/L PCA, P. putida
RL-PYO on the other hand only produced a maximum of 50.0 ± 10.0 mg/L mono-rhamnolipids,
48.8 ± 0.2 mg/L PCA, and 14.7 ± 0.3 mg/L PYO (Figure 2). In contrast, the best performing clone of the
control strain P. putida RL produced 730 mg/L mono-rhamnolipids in LB media and 360 ± 30 mg/L in
Delft minimal medium containing 10 g/L of glucose after 30 h of cultivation, respectively (Figure S2 and
Figure 2). All four common mono-rhamnolipid congeners naturally produced by P. aeruginosa were
present in the engineered P. putida strain (i.e., Rha-C10-10 (predominantly), Rha-C10-C8, Rha-C10-C12,
and Rha-C10-C12:1). For the P. putida RL-MS control strain, the best performing clone produced
a maximum of 840 mg/L mono-rhamnolipids in LB media (Figure S2) and 400 ± 20 mg/L in the Delft
minimal media (Figure 2), while some of the tested clones did not produce any mono-rhamnolipids.
This shows the great variability of successful mono-rhamnolipid production.
The best performing P. putida RL-PCA and P. putida RL-PYO clones, as well as the non-phenazine
controls from the micro-cultivation, were further characterized under aerobic conditions in shake flasks
(Figure 3). Here, P. putida RL-PCA was able to produce a maximum of 141 mg/L mono-rhamnolipids
and 57.7 ± 18.4 mg/L PCA after 48 h of fully aerobic cultivation. Thereby, the mono-rhamnolipid
production of this strain was higher than that of the non-PCA producing P. putida RL strain, which only
produced 110.0 ± 0.3 mg/L mono-rhamnolipids. By doubling the concentration of the inducer salicylate
(to 2 mM), mono-rhamnolipid and PCA production further increased up to 152.0 ± 1.2 mg/L and
122.0 ± 12.5 mg/L, respectively. In the same set-up, the P. putida RL-PYO clone only produced 50 mg/L
mono-rhamnolipids and 67.2 ± 7.8 mg/L PCA, as well as 34.0 ± 2.8 mg/L PYO. Here, the increase of
the inducer concentration did not enhance the mono-rhamnolipid production, but increased PCA
production to 130.8 ± 16.8 mg/L. Further, a reduced overall growth, as seen by the lower OD600 values,
compared to the P. putida RL-PCA and P. putida RL strains was recorded. We therefore concluded
that the ability of P. putida to produce PYO is of no advantage, but rather has a negative impact
on RL production. Hence, the P. putida RL-PCA strain was chosen to be further characterized for
bioelectrochemical production of rhamnolipids.
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Figure 3. Fully aerobic flasks cultivation of different P. putida strains for mono-rhamnolipid and
phenazine production (PCA and PYO). Non-phenazine producing control strains shown in black traces
(circles). Phenazine production strains are shown in green (triangles). *: doubled amount of salicylate
inducer (2 mM vs. normally 1 mM; orange squares). Growth measurement via optical density at
600 nm for (a) P. putida RL-PCA strain and P. putida RL control and (b) P. putida RL-PYO and P. putida
RL control in Delft minimum media containing 10 g/L glucose. (c,d) show the respective rhamnolipid
production (solid traces), PCA production (dashed traces) and PYO production (dotted traces) of these
cultivations. (n = 3; error bars represent standard deviations).
3.2. Bioelectrochemical Production of Rhamnolipids in Oxygen-Limited BES
3.2.1. Applying Active Aeration to the Benchtop BES Reactors
We have previously shown that the highest PCA- as well as current production can be achieved
when P. putida PCA is cultivated in an initially actively aerated BES, which is switched to passive aeration
after 48 h (active aeration (AA) set-up) [19]. With this configuration an increased biomass formation is
enabled during the active aeration period, as P. putida is an obligate aerobic organism, and the cells
have a high metabolic activity when oxygen is available in sufficient amounts. This increased quantity
of cells can than produce an ample concentration of PCA via plasmid-based expression. In order to
mediate electrons to the anode and to generate a detectable current signal, rather than passing them
onto oxygen, the concentration of the latter needs to be reduced. Hence, during the passive aeration
phase, when metabolism is slowed, the anode is more incorporated, and the viability of the cells is
secured for a longer time period. Therefore, the AA set-up was our initial configuration of choice
for the bioelectrochemical characterization of the strains. As a control experiment, first the P. putida
RL strain, solely able to produce mono-rhamnolipid but no PCA was characterized in AA-mode BES
reactors at 0.2 V and without an applied potential to the electrode; hence, at open circuit potential
(OCP; Figure S3). Here, no mono-rhamnolipids were produced. Next, the P. putida RL-PCA strain was
tested in AA-mode BES reactors at OCP (Figure S4) and also did not produce any detectable amounts of
mono-rhamnolipids under these oxygen-limited conditions. After these control experiments, we tested
if the presence of a redox mediator and an anode poised at 0.2 V in an oxygen-limited BES would be
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beneficial for P. putida RL-PCA cultivation, as the electrode could potentially be used as an alternative
terminal electron acceptor to support rhamnolipid production.
Therefore, we first tested the performance of the generated P. putida RL-PCA strain at 0.2 V with the
AA regime (Figure S5). Here, the strain produced 75.7 ± 13.8 mg/L PCA, resulting in a current density
of 10.6 ± 3.2 µA/cm2, which was in a similar range as in our previous work [19]. In 10 days, 89% of the
provided glucose was consumed with minor amounts of 2-ketogluconate, an oxidation product of
glucose [28], formed during the first three days. However, no detectable amount of mono-rhamnolipid
was produced by the P. putida RL-PCA strain in this set-up during the 10 days of operation.
In the following, we switched the operation to 50 mL/min continuous active aeration throughout
the entire experiment (AA+). This configuration aimed at providing higher amounts of oxygen
to be available as electron acceptor for cellular catabolic reactions to support the production of
mono-rhamnolipids (Figure S5). While the PCA production was increased by 16% compared to the
AA regime, still no mono-rhamnolipids were produced. The increased amount of PCA led to a 30%
increase in the maximum current density to 13.7 ± 1.8 µA/cm2. This was achieved with a glucose
consumption of 93%. This result indicates that the lack of oxygen was likely not the main limiting
factor for the production of mono-rhamnolipids in the BES reactors.
3.2.2. Applying Passive Aeration to the Benchtop Single Chamber Glass BES Reactors
To complete our evaluation of different aeration regimes in BESs, we finally also operated the
reactors with a continuous passive aeration (PA) of the headspace, i.e., providing even less oxygen
to the culture than before. Surprisingly, under this stringent oxygen-limited condition, P. putida
RL-PCA was able to produce low concentrations of mono-rhamnolipids of up to 30.4 ± 4.7 mg/L. It also
produced 11.2 ± 0.8 mg/L of PCA, which resulted in a maximum current density of 8.1 ± 0.1 µA/cm2,
at a substantially lower consumption of glucose, with 41% of the initially provided carbon source still
present by the end of the experiment after 10 days (Figure 4a–c). Note that the reactors had a substantially
lower cell density with an OD600 of ~1, as compared to the shake flasks experiments (Figure 3), partially
accounting for the low rhamnolipid titer. This reduced OD600 is most likely due to an overall decreased
biomass formation, as P. putida is known to be an obligate aerobic organism [29]. The dominating
rhamnolipid congener still was Rha-C10-C10 with about two-thirds of the total mono-rhamnolipids,
followed by Rha-C10-C12, RhaC10-C12:1 and only minute amounts of Rha-C10-C8. The experiment
was repeated independently in triplicates with very similar results (Figure S6).
3.2.3. Scaling-Up and Verification of Results in 1-L Electrobioreactors
To evaluate if a BES-based oxygen-limited rhamnolipid production can be robustly implemented
in a more controlled setting, we applied the P. putida RL-PCA strain in 1-L electrobioreactors [20].
In the passively aerated benchtop reactors the pH decreased to 6.09 ± 0.7 by the end of the experiment,
and low pH can be growth inhibiting [30]. In the electrobioreactors, the pH was controlled to not
drop beneath 6.5 and the experiments were conducted over a longer period of time (Figure 4d–f).
The electrobioreactors were inoculated with a higher cell density as compared to the benchtop reactors
(0.4 vs. 0.1, respectively) and a higher final cell density was reached (1.7 vs. 1.2). PCA was produced in
comparable amounts in the two set-ups. After 10 days, which was the length of the benchtop BES
reactor experiment, 15.4 ± 1.0 mg/L PCA was produced in the electrobioreactor. This value increased
to up to 25.7 ± 8.0 mg/L by the end of the experiment after 25 days. After 10 days, 51% of the available
glucose was consumed in the passively aerated electrobioreactor, whereby more 2-ketogluconate was
produced than in the benchtop reactors. By the end of the experiment, after 25 days, glucose was
completely consumed, while some 2-ketogluconate remained unused (3.7 ± 0.5 mM). Most importantly,
we were able to verify the production of rhamnolipids. They were mainly produced in the first 24 h of
the experiment with up to 30.5 ± 0.5 mg/L, which is very similar to the benchtop titers. After this initial
increase, the detectable amount of rhamnolipids gradually declined until the end of the experiment.
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While in one of the duplicate reactors still 45% of the originally produced mono-rhamnolipids could be
detected, no rhamnolipids were measurable in the second reactor on day 25.
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Figure 4. Passively aerated BES reactors of P. putida RL-PCA at an applied potential of 0.2 V. (a–c) Benchtop
BES reactors (n = 3), showing data for cell density (OD600) and current production, glucose consumption
and 2-ketogluconate production, formation of PCA and rhamnolipids (RL). (d–f) Electrobioreactors
(n = 2), with the equivalent data shown as for the benchtop reactors. The dotted lines indicate the length
of the benchtop BES reactor experiment. Gluconate and acetate were not detected in these experiments
and are therefore not shown.
To verify that indeed rhamnolipid production was only possible when the electrobioreactors were
operated at passive aeration, a control experiment with applying active aeration for the initial 24 h
(controlled at 0.8 L/min) was conducted (Figure S7). Like in the benchtop BES (Figure S5), PCA was
produced throughout the experiments, reaching titers of up to 100 mg/L, while no rhamnolipids could
b detected.
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4. Discussion
We here describe the production of mono-rhamnolipids in the industrially relevant strain P. putida
KT2440 under stringent oxygen-limited conditions. To achieve this, we enabled an alternative electron
discharge of surplus metabolic electrons via electron shuttling to an extracellular electrode of a BES
with heterologously produced phenazine redox mediators. The successful introduction of the rhlAB
operon, originating from P. aeruginosa PAO1, into P. putida KT2440 for the heterologous production of
rhamnolipids has been described previously (Table 2). This non-pathogenic bacterium possesses both
critical pathways for the rhamnolipid precursor biosynthesis, activated rhamnoses and hydroxyalkanoic
acids (Figure 1), respectively and grows well on glucose [9–11]. It is therefore a more suitable host
than E. coli for a straight forward biodetergent production within a bioeconomy strategy. The here
developed strain P. putida RL-PCA is additionally equipped to produce the P. aeruginosa PA14-derived
phenazine PCA (Figure 1). We also constructed a P. putida strain, which has the genetic capacity
to produce PCA as well as PYO in addition to the rhamnolipids (P. putida RL-PYO). These strains
were initially characterized in fully aerobic cultivations to evaluate the impact of a co-production of
phenazines on rhamnolipid synthesis. The concentrations of rhamnolipids in complex LB medium
were generally 2–3 times higher than in minimal Delft medium. However, for a more quantitative
evaluation of the subsequent bioelectrochemical experiments, the Delft medium was chosen as the main
working medium. The non-phenazine producing control strains synthesized between 110 and 140 mg/L
mono-rhamnolipids in this medium in shake flasks (Figure 3). This value was slightly increased when
combined with PCA production, but drastically decreased when also PYO was produced (to only
35% of the P. putida RL-PCA level). Of the two phenazines, PYO is known to be more reactive and
induces higher levels of oxidative stress [31–33]. Typically, also lower concentrations of PYO than of
PCA are synthesized and tolerated by the cells to adjust to the increasing toxicity of PYO at higher
concentrations. This increased stress in the presence of PYO might explain the reduced rhamnolipid
production in the P. putida RL-PYO strain. We therefore focused our further investigations on the
strain producing PCA as the sole phenazine (P. putida RL-PCA). During all aerobic cultivations of our
newly engineered P. putida strains, we found all four common mono-rhamnolipid congeners that are
naturally produced by P. aeruginosa in the expected ratio (i.e., predominantly Rha-C10-10, followed by
Rha-C10-C8, Rha-C10-C12, and Rha-C10-C12:1) [34].
The then following evaluation of rhamnolipid production under oxygen-limited BES conditions
led to surprising outcomes. In previous studies, we had assessed the oxygen-limited growth and
phenazine-based electron discharge under different oxygenation levels [18,19]. There, we found the
best performance with a mixed regime of an initial low-level aeration of the medium for biomass
growth followed by a passive aeration of the headspace for current production. Completely anaerobic
growth and maintenance of P. putida cells is generally not possible, since many essential metabolic
reactions in this organism depend on oxygen [29]. Therefore, we first reproduced this initial active
aeration protocol and while both, growth and PCA production were similar to the previous results [19],
no rhamnolipids were produced. Anticipating that the limitation of oxygen was the reason for the
absence of rhamnolipid production, we increased the aeration to a continuous medium level (50 mL/min)
throughout the experiment; however, this did not lead to rhamnolipid production. We finally switched
to our most constraint aeration regime, where only passive aeration of the headspace provides some
oxygen. Despite the expected slower growth, glucose consumption, and the therefore reduced PCA
synthesis (to only about one third), mono-rhamnolipids were produced. The concentration was only
about 15–20% compared to the aerobic cultivations in shake flasks, but a reduced production under
energetically very difficult circumstances was expected. We scaled this experiment up to 1 L using fully
integrated electrobioreactors, which combine the electrochemical control with classical state-of-the-art
bioreactor operation, including pH and oxygen control. Our results from the benchtop BES were
fully confirmed—no rhamnolipid production with active aeration and—almost identical—surfactant
production with only passive aeration of the reactors. These experiments ran more than twice as long
and for the stationary phase we observed a slow degradation of the produced rhamnolipids.
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We hypothesize that during active aeration of the culture, oxygen still was an extremely efficient
electron acceptor and although glucose metabolism and respiration processes slowed down compared
to shaken cultures, there was no overload with reducing equivalents within the cell. In contrast
under passive aeration, the availability of oxygen to the cells was purely determined by diffusion
and mixing of the BES liquid volume and oxygen became very scarce. Reducing equivalents like
NAD(P)H generated from glucose, had to find alternative pathways for regeneration. One of these
sinks for NAD(P)H utilization is the synthesis of activated hydroxyalkanoic acids in lipid de novo
synthesis, which in turn are substrates for rhamnolipid production. Thus, while a part of the reducing
equivalents was regenerated by charging the phenazines that were subsequently discharged at the
anode, more regeneration was enabled by storing the electrons away in rhamnolipids. We know from
our own and independent other group’s work that naturally phenazine-based extracellular electron
discharge in Pseudomonas is restricted. The coulombic efficiency (fraction of electrons from the substrate
harvested at the anode) is typically <10% [18,19,35] (here, maximum ~4.3% for passive aeration)
and physiological investigations showed that while cells can maintain their metabolic functions,
only a low level of ATP production and no growth is possible [18,19,36,37]. Several efforts are on
the way to determine the physiological interaction partners of phenazines and to clarify the native
electron transfer route. Research also focuses to re-engineer this extracellular electron transfer to be
more efficient for the cell. However, based on what we found here, this should be very carefully
controlled. Opening the doors to extracellular electron transfer too much might lead to a similar result
as in actively aerated BES, were the glucose substrate is fully respired and no reduced rhamnolipid
by-products are produced. Thus, a medium level respirative energy generation for controlled restricted
growth at a surplus of reducing equivalents, which push for detergent production, might be the best
scenario for this specific metabolic product. Especially for passive aeration, the amount of oxygen
available to the cell will greatly depend on external factors like the reactor geometry and the size of the
vent filters. With the data measured in this study, it is not possible to appoint a specific set-point for the
oxygen concentration needed for rhamnolipid production. During passive aeration in the benchtop
BES, we are very close to the detection limit of the used oxygen sensors and in the electrobioreactors
no measurement was available during PA set-up. However, a basal requirement for oxygen for many
metabolic functions within P. putida is certain [29]. To our knowledge, no study further determined
how high this minimum obligate O2 concentration needs to be in order for this organism to sustain
a fully functional cellular metabolism. This important parameter needs to be determined in the future
to make electrobioproduction with P. putida more applicable.
To relate the rhamnolipid production of our strains to other attempts of heterologous rhamnolipid
synthesis, we compare the mono-rhamnolipid titers for productions with Pseudomonas putida strains
(Table 2). With glucose, titers of other strains, which have been engineered and further optimized
for rhamnolipid production, reach 1.25–3 g/L in complex LB media. Our plasmid-based synthesis
of rhamnolipids (without phenazines) reached about 0.75 g/L in complex media. Thus, for complex
media, we are close to the state-of-the-art of heterologous rhamnolipid synthesis without any further
strain optimization. In minimal media, the reached titers were with up to 0.36 g/L (without phenazines)
and 0.15 g/L (with phenazines) still quite a bit lower. However, all those reported data are still far below
an economic range and more strain engineering as well as bioprocess development work is required.
Compared to the aerobic synthesis of rhamnolipids in minimal medium, the strictly oxygen-limited
production in BES only reached titers of 0.03 g/L, i.e., one fifth of the aerobic concentration. While this
is much lower, it should be recognized that hardly any oxygen as energetic driver was required for
this production.
To conclude, we here showed for the first time the production of a biotechnologically relevant
product under strictly oxygen-limited conditions with an obligate aerobic host using microbial
electrosynthesis. Cellular maintenance energy was generated through extracellular electron transfer to
an anode, which allowed for surplus reducing equivalents to be put forward to product synthesis. Thus,
this work opens doors to oxygen-limited (and maybe in future anaerobic) production of highly energetic
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products, which normally require a well energized cell metabolism. With further improvements of the
energetic interaction between Pseudomonas cells and the anode as electron acceptor, this process can
be further enhanced, and relevant product concentrations can likely be reached. Beyond this work,
this study also opens the path to the electrobiotechnological production of other types of glycolipid
surfactant under oxygen limitation; or entirely different products, which might suffer from the presence
of oxygen, such as redox active metabolites or proteins.
Table 2. Recombinant rhamnolipid production in batch experiments in this study compared to other
Pseudomonas producers.
Organism Medium Substrate(conc. in g/L) Duration
Maximal RL
Titer (g/L) Growth Condition Ref.
P. putida
KT42C1 pVLT31_rhlAB LB Glucose (10) 42 h 1.5 Flask, aerobic [11]
P. putida
KT2440 pSynPro8 LB Glucose (10) 22 h 3.22 Flask, aerobic [10]
P. putida KT2440 *
pSynPro8oT ModR Glucose (253) 72 h 14.9
Benchtop bioreactor,
aerobic [38]
P. putida KT2440 ∆flag SK4 Delft Glucose (11) 10 h 1.48 Benchtop bioreactor,aerobic [16]
P. putida RL KT2440
pJNN.rhlAB LB Glucose (10) 30 h 0.73 Microscale, aerobic this study
P. putida RL KT2440














Flask, aerobic this study
P. putida RL-PCA KT2440
pJNN.rhlAB_pBNT.14phz2 Delft Glucose (5) 10 d 0.02 Benchtop BES, PA ** this study
P. putida RL-PCA KT2440
pJNN.rhlAB_ pBNT.14phz2 Delft Glucose (5) 25 d 0.03 Electrobioreactor BES, PA ** this study
* Data in this row represent the highest titer achieved with recombinant P. putida. However, this process was
operated in fed-batch with a continuous glucose feed and does not allow for direct comparison with other presented
data from batch operations. ** PA: passive aeration via open vent filters.
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